SS Innovations Wins 2026 Surgical Robotics Industry Outstanding Company Award

SS Innovations International wins the 2026 Surgical Robotics Industry Outstanding Company Award, highlighting its SSi Mantra system's growing adoption with over 11,700 procedures completed and regulatory approval in 14 countries.

SD Metrowire Staff
Healthcare
SS Innovations Wins 2026 Surgical Robotics Industry Outstanding Company Award

SS Innovations International, Inc. (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, recognizing the company's excellence in innovation, commercial success, industry leadership and positive societal impact. The award reflects growing adoption of its SSi Mantra surgical robotic system, which the company believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.

As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also said approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. The award underscores the system's impact in making robotic surgery more accessible globally.

For more details, the full press release is available at https://ibn.fm/XWdRe. SS Innovations International, Inc. (NASDAQ: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.

This recognition is significant because it validates the commercial and clinical progress of the SSi Mantra system, which is designed to compete with established players by offering lower costs and broader accessibility. The award may enhance the company's credibility and visibility among healthcare providers and investors, potentially accelerating adoption in new markets.

Blockchain Registration

QR Code for Blockchain Registration